Skip to main navigation
Skip to search
Skip to main content
Monash University Home
Help & FAQ
Home
Profiles
Research units
Equipment
Projects
Outputs
Prizes
Activities
Press/Media
Search by expertise, name or affiliation
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER, PHASE 2 STUDY TO EVALUATE THE EFFICACY, SAFETY, AND PHARMACOKINETICS OF ROZANOLIXIZUMAB IN ADULT STUDY PARTICIPANTS WITH LEUCINE-RICH GLIOMA INACTIVATED 1 AUTOIMMUNE ENCEPHALITIS
Monif, Mastura
(Primary Chief Investigator (PCI))
Department of Neuroscience
Project
:
Research
Overview
Project Details
Status
Finished
Effective start/end date
24/08/21
→
31/12/24
View all
View less
Keywords
Autoimmune encephalitis
Neurology
Neurosciences
Clinical trial